Aortic stenosis trials in China

In China 42 Also abroad 232

17 of 42 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Sapien 3 Transcatheter Aortic Valve Replacement in Young Aortic Valve Stenosis Patients From China
Where
Beijing, Chengdu, Shanghai, Xi'an
Age
50 years to 70 years
People
450
Run by
Xijing Hospital
See details and how to joinNCT06830499
No phaseNot yet taking people in China
Active Post-Market Surveillance of Innovative Devices for Valvular Heart Disease
Where
Beijing
Age
18 years and over
People
5,500
Run by
Beijing Anzhen Hospital
See details and how to joinNCT07605624
No phaseNot yet taking people in China
A Prospective, Multicenter, Observational Study Evaluating Safety and Effectiveness of SAPIEN 3 Transcatheter Aortic Valve Replacement for Type-0 Bicuspid Aortic Valve Stenosis Patients in China
Where
Beijing
Age
50 years and over
People
170
Run by
Chinese Academy of Medical Sciences, Fuwai Hospital
See details and how to joinNCT07450196
No phaseTaking people
Noninvasive Real-Time Arterial Waveform Monitoring for Cardiovascular Disease Assessment
Where
Hefei
Age
18 years to 80 years
People
15
Run by
Anhui Provincial Cancer Hospital
See details and how to joinNCT07350629
No phaseTaking people
Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease
Where
Beijing, Changsha, Chengdu, Chongqing, Fuzhou, Hangzhou, Kunming, Qingdao, Shanghai, Shenyang, Ürümqi, Wuhan, Xi'an
Age
18 years and over
People
10,000
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07267117
No phaseNot yet taking people in China
A Prospective, Multicenter, Observational Study of the Safety and Efficacy of Emergency Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis
Where
Jinan
Age
70 years and over
People
35
Run by
Qilu Hospital of Shandong University
See details and how to joinNCT07108478
No phaseEnrolling by invitation
A Clinical Study on the Use of the Sentinel Cerebral Protection Device During TAVR for the Prevention of Procedure-Related Stroke
Where
Beijing
Age
18 years and over
People
200
Run by
China National Center for Cardiovascular Diseases
See details and how to joinNCT07045233
No phaseTaking people
Changes of Ascending Aortic Diameter in Patients Undergoing Transcatheter Aortic Valve Replacement
Where
Beijing
People
480
Run by
China National Center for Cardiovascular Diseases
See details and how to joinNCT05739253
No phaseTaking people
A Study of Chinese Congenital Bicuspid Aortic Valve
Where
Shanghai
Age
14 years to 60 years
People
500
Run by
Ruijin Hospital
See details and how to joinNCT06802016
No phaseTaking people
An Integrated Prenatal and Postnatal Treatment Model for the Treatment of Newborns With Critical Congenital Heart Disease
Where
Beijing
Age
1 day to 28 days
People
10,000
Run by
Beijing Anzhen Hospital
See details and how to joinNCT06768008
No phaseTaking people
Prospective Observational Cohort Study of Moderate Aortic Valve Disease
Where
Hangzhou
Age
18 years and over
People
1,000
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06595992
No phaseTaking people
Modified Aortic Root Enlargement Procedure
Where
Beijing
Age
50 years to 70 years
People
64
Run by
China National Center for Cardiovascular Diseases
See details and how to joinNCT06517537
No phaseTaking people
Long-term Prognosis and Valve Durability of TAVR
Where
Xi'an
Age
18 years and over
People
1,000
Run by
Xijing Hospital
See details and how to joinNCT06379386
No phaseTaking people
Aortic Valve Diseases RISk facTOr assessmenT and Prognosis modeL Construction
Where
Guangzhou, Jieyang, Shantou, Shenzhen, Zhanjiang, Zhongshan
Age
18 years to 100 years
People
2,000
Run by
Sun Yat-sen University
See details and how to joinNCT06069232
No phaseNot yet taking people in China
VitaFlow® Transcatheter Aortic Valve Replacement System Pre-market Trial Long Term Follow Up （VITAL）
Where
Beijing, Chengdu, Hangzhou, Shanghai
Age
18 years and over
People
89
Run by
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
See details and how to joinNCT05977257
No phaseTaking people
SMART Watch Facilitated Early Discharge in Patients Undergoing Transcatheter Aortic Valve Replacement
Where
Hangzhou
Age
18 years and over
People
100
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT04454177
No phaseTaking people
VitaFlow™ Transcatheter Aortic Valve System Post-market Study-The LAUNCH Study
Where
Shanghai
Age
70 years and over
People
100
Run by
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
See details and how to joinNCT04414865